ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 104 filers reported holding ADICET BIO INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $167,574 | +38.1% | 122,317 | +145.0% | 0.00% | – |
| Q2 2023 | $121,303 | -94.0% | 49,919 | -85.8% | 0.00% | – |
| Q1 2023 | $2,030,843 | -45.7% | 352,577 | -15.7% | 0.00% | -100.0% |
| Q4 2022 | $3,739,137 | -11.5% | 418,248 | +40.8% | 0.00% | 0.0% |
| Q3 2022 | $4,225,000 | +121.9% | 297,127 | +127.8% | 0.00% | – |
| Q2 2022 | $1,904,000 | -17.6% | 130,441 | +12.8% | 0.00% | – |
| Q1 2022 | $2,310,000 | +39.8% | 115,675 | +22.5% | 0.00% | – |
| Q4 2021 | $1,652,000 | +365.4% | 94,448 | +232.3% | 0.00% | – |
| Q1 2021 | $355,000 | – | 28,422 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 728,944 | $998,653 | 0.37% |
| DAFNA Capital Management LLC | 797,054 | $1,091,964 | 0.34% |
| COWEN AND COMPANY, LLC | 2,715,278 | $3,719,930 | 0.26% |
| Orbimed Advisors | 8,322,140 | $11,401,332 | 0.24% |
| TANG CAPITAL MANAGEMENT LLC | 1,226,352 | $1,680,102 | 0.24% |
| Carlyle Group Inc. | 2,115,385 | $2,876,924 | 0.12% |
| RTW INVESTMENTS, LP | 4,241,472 | $5,810,817 | 0.12% |
| Acuitas Investments, LLC | 136,779 | $187,387 | 0.11% |
| Decheng Capital Management III (Cayman), LLC | 200,201 | $274,275 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 142,168 | $195 | 0.02% |